Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Treatment of Recurrent H3 K27M-Mutant Diffuse Midline Glioma. Show all posts
Showing posts with label Treatment of Recurrent H3 K27M-Mutant Diffuse Midline Glioma. Show all posts
Monday, December 15, 2025

FDA Grants Accelerated Approval to Modeyso (dordaviprone) for the Treatment of Recurrent H3 K27M-Mutant Diffuse Midline Glioma

›
Jazz Pharmaceuticals plc (Nasdaq: JAZZ)  announced the U.S. Food and Drug Administration (FDA) accelerated approval of  Modeyso (dordavipron...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.